Showing Results for
- Academic Journals (2)
Search Results
- 2
Academic Journals
- 2
-
From:PLoS ONE (Vol. 16, Issue 8) Peer-ReviewedBackground The benefit of tocilizumab on mortality and time to recovery in people with severe COVID pneumonia may depend on appropriate timing. The objective was to estimate the impact of tocilizumab administration on...
-
From:PLoS ONE (Vol. 15, Issue 11) Peer-ReviewedAims The aim of this study was to estimate a 48 hour prediction of moderate to severe respiratory failure, requiring mechanical ventilation, in hospitalized patients with COVID-19 pneumonia. Methods This was an...